SUGAMMADEX

This page contains brief details about Sugammadex, its indication, dosage and administration, mechanism of action, related brands with strength, warnings, and common side effects.

Sugammadex is a medication that helps people wake up quickly after surgery. It reverses the effects of certain drugs that relax muscles during the operation. This allows patients to breathe and move on their own again, helping them recover smoothly after the procedure.

Sugammadex can be administered intravenously. The dosage and administration of this medication will be determined by a healthcare provider based on the specific needs of the patient and the medical procedure being performed.

Sugammadex may cause some side effects, although they are typically not very common. Common side effects may include nausea, vomiting, headache, and shivering. Serious side effects are rare but may include severe allergic reactions, which can manifest as difficulty breathing, swelling of the face, lips, or tongue, and a sudden drop in blood pressure.

Patients with compromised respiratory function may experience respiratory depression or other breathing difficulties after the administration of Sugammadex. While rare, cases of anaphylaxis have been reported with the use of this medication.

Monitor patients closely for any signs of respiratory distress or compromised breathing both during and after the administration of Sugammadex. Educate patients about the potential signs of severe allergic reactions and encourage them to seek immediate medical attention if any symptoms occur.

Assess for any prior hypersensitivity to Sugammadex or its components. In patients with renal or hepatic impairment, close monitoring is warranted as dose modification may be required. Weigh the risks against benefits before administering during pregnancy or lactation. Exercise caution when used concurrently with other medications, as drug interactions are possible. Elderly patients warrant careful observation for adverse effects. Patients with respiratory or cardiovascular disease require close monitoring during administration. Remain alert for signs of hypersensitivity in those with a prior history of allergic responses to other medications. Account for potential effects in patients with underlying neuromuscular, haemorrhagic, or electrolyte disturbances. Regular assessment of vital parameters—including blood pressure, heart rate, and respiratory rate—is essential to detect and address any adverse events or complications that may emerge during treatment.

Merck Sharp & Dohme, Electronic Medicines Compendium (EMC), [Revised on 03 Aug 2023] [Accessed on 27th Oct 2023], https://www.medicines.org.uk/emc/product/14949/pil#gref Merck Sharp & Dohme Corp., U.S. Food and Drug Administration, [Revised on December 2015], [Accessed on 27th Oct 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022225lbl.pdf KD Tripathi, Essentials of Medical Pharmacology, Drugs Acting on Peripheral (Somatic) Nervous System, 7th edition, 2013, 355.